Allicillin
Allicillin, licence 80073591: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80073591
- Status
- Active licence
- Licence date
- 7 November 2016
- Revision date
- 31 October 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Allium sativum Source : Bulbe | 40.0 mg | Not calculated |
| Petroselinum crispum Source : Graine(s) | 2.0 mg | Not calculated |
Non-medicinal ingredients
Glycérine, Cire de Carnauba, Extrait de roucou, Annatto, Cire d'abeille, Eau, Glaçure pharmaceutique, Huile d'olive, Lécithine, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help relieve the symptoms associated with upper respiratory tract infections and catarrhal conditions.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood thinners or protease inhibitors.
Source
Official Health Canada record, licence 80073591
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.